Psychiatry & Neurology, Child & Adolescent Psychiatry · Howell, MI
NPI
1598896367
Since 2007
Specialty
Psychiatry & Neurology, Child & Adolescent Psychiatry
Code 2084P0804X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2901 E Grand River Ave
Howell, MI, 48843
Phone (517) 548-1537
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
1,281 services
Medicare patients, 2024
143
Average age 66
Drug cost, 2024
$272K
3,452 prescriptions
Company payments, 2025
$807
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Viken R Matossian was code 90837 (psychotherapy - nongroup), 538 times for 57 patients. In total Viken R Matossian billed 1,281 services in 15 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90837 Psychotherapy - Nongroup | Office | 538 | 57 | $104.92 | $56K |
| 99214 Office E&M - Established | Office | 392 | 112 | $74.33 | $29K |
| 90833 Psychotherapy - Nongroup | Office | 94 | 40 | $48.06 | $4,517 |
| 90791 Psychotherapy - Nongroup | Office | 25 | 25 | $120.25 | $3,006 |
| 90792 Psychotherapy - Nongroup | Office | 20 | 20 | $147.44 | $2,949 |
| 99213 Office E&M - Established | Office | 20 | 19 | $29.56 | $591 |
By year: 2022 $134K for 1,443 services; 2023 $128K for 1,405 services; 2024 $117K for 1,281 services.
Medicare prescription drug claims, 2024
In 2024, the drug Viken R Matossian prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 264 prescriptions and refills. In total Viken R Matossian wrote 3,452 Medicare prescriptions that cost $272K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Bupropion Xl Bupropion Hcl | 264 | 510 | 62 | $5,946 |
| Quetiapine Fumarate Generic | 234 | 394 | 47 | $2,871 |
| Duloxetine Hcl Generic | 233 | 469 | 56 | $6,945 |
| Lamotrigine Generic | 180 | 323 | 44 | $2,447 |
| Clonazepam Generic | 142 | 180 | 26 | $1,041 |
| Methylphenidate Hcl Generic | 141 | 173 | 23 | $3,003 |
| Trazodone Hcl Generic | 105 | 187 | 26 | $1,008 |
| Alprazolam Generic | 101 | 131 | 17 | $625 |
| Lorazepam Generic | 92 | 116 | 24 | $844 |
| Escitalopram Oxalate Generic | 88 | 166 | 20 | $1,137 |
| Mirtazapine Generic | 80 | 136 | 17 | $998 |
| Risperidone Generic | 78 | 136 | 17 | $801 |
| Gabapentin Generic | 76 | 109 | 19 | $1,282 |
| Methylphenidate Er Methylphenidate Hcl | 75 | 105 | 18 | $9,858 |
| Trintellix Vortioxetine Hydrobromide | 72 | 110 | 12 | $48K |
Brand drugs: 186 claims; generic drugs: 3,266 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Viken R Matossian $807 ($807 in general payments such as food, travel and fees) from 12 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $152.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $152 |
| Alkermes, Inc. ALKS | 3 | $87.77 |
| Lundbeck LLC | 4 | $87.02 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $74.58 |
| Abbvie Inc. ABBV | 4 | $71.23 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $67.45 |
| Corium, LLC | 2 | $60.19 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $59.1 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $52.13 |
| Novo Nordisk Inc NVO | 2 | $33.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.